# Interferon Alpha Lozenges in the Prevention of Winter Colds and Flu

> **NCT00895947** · PHASE2 · COMPLETED · sponsor: **Ainos, Inc. (f/k/a Amarillo Biosciences Inc.** · enrollment: 200 (actual)

## Conditions studied

- Upper Respiratory Tract Infections

## Interventions

- **DRUG:** interferon-alpha
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00895947
- **Lead sponsor:** Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-01
- **Final completion:** 2010-03
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2011-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00895947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00895947, "Interferon Alpha Lozenges in the Prevention of Winter Colds and Flu". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00895947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*